Nichelle Sage
About Nichelle Sage
Nichelle Sage is the Associate Director of Global Dossier Management at Bristol-Myers Squibb, with extensive experience in regulatory affairs and a proven track record of improving submission timelines and compliance rates.
Current Position at Bristol-Myers Squibb
Nichelle Sage currently serves as the Associate Director of Global Dossier Management at Bristol-Myers Squibb. In this role, she is instrumental in overseeing and streamlining the global dossier management process, ensuring compliance with various regulatory requirements. She brings her extensive experience in regulatory submissions to enhance the efficiency and effectiveness of the dossier management practices within the company.
Past Roles at Bristol-Myers Squibb
Prior to her current role, Nichelle Sage worked as a Senior Submission Manager at Bristol-Myers Squibb from 2017 to 2019 in New Jersey. During her tenure, she was responsible for managing submission timelines and improving compliance rates across various regulatory affairs projects. Her efforts significantly contributed to the company's efficiency in regulatory documentation processes.
Experience at Eli Lilly and Company
Nichelle Sage has held multiple roles at Eli Lilly and Company. From 2015 to 2017, she served as Principal Associate in Global Regulatory Affairs for North America. Before this, she was Coordinator III for Central Regulatory Registration from 2013 to 2015 in Bridgewater, NJ. Additionally, she worked as a Senior Assistant in Clinical Trials at ImClone Systems, a subsidiary of Eli Lilly, from 2011 to 2013. In these roles, she gained comprehensive experience in managing regulatory submissions for small molecules and biologics.
Earlier Career at Merck
Nichelle Sage began her career at Merck as a Clinical Documentation Associate from 2010 to 2011. In this position, she was responsible for handling clinical documentation, which laid the foundation for her subsequent roles in regulatory affairs and dossier management.
Educational Background
Nichelle Sage graduated from The College of New Jersey with a Bachelor of Science degree in Biology, General, in 2009. Her educational foundation provided her with the necessary knowledge and skills that have been integral to her success in the pharmaceutical and regulatory affairs industry.